Correction: Chapman, E.; et al. Inhibitors of the AAA+ Chaperone p97. Molecules 2015, 20, 3027-3049

By Chapman Eli   Maksim Nick   de la Cruz Fabian   La Clair James J.  

Molecules, Vol. 20, Iss. 3, 2015-03 ,pp. : 4357-4358

MDPI

Access to resources Recommend Favorite

Stability of the Human Hsp90-p50^Cdc37 Chaperone Complex against Nucleotides and Hsp90 Inhibitors, and the Influence of Phosphorylation by Casein Kinase 2

By Olesen Sanne H.   Ingles Donna J.   Zhu Jin-Yi   Martin Mathew P.   Betzi Stephane   Georg Gunda I.   Tash Joseph S.   Schönbrunn Ernst  

Molecules, Vol. 20, Iss. 1, 2015-01 ,pp. : 1643-1660

MDPI

Access to resources Recommend Favorite

Effects of P-Glycoprotein and Its Inhibitors on Apoptosis in K562 Cells

By Zu Yaqiong   Yang Zhiyong   Tang Songshan   Han Ying   Ma Jun  

Molecules, Vol. 19, Iss. 9, 2014-08 ,pp. : 13061-13075

MDPI

Access to resources Recommend Favorite

Insights on Cytochrome P450 Enzymes and Inhibitors Obtained Through QSAR Studies

By Sridhar Jayalakshmi   Liu Jiawang   Foroozesh Maryam   Klein Stevens Cheryl L.  

Molecules, Vol. 17, Iss. 8, 2012-08 ,pp. : 9283-9305

MDPI

Access to resources Recommend Favorite

Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome

By Bagley Mark C.   Davis Terence   Murziani Paola G. S.   Widdowson Caroline S.   Kipling David  

Pharmaceuticals, Vol. 3, Iss. 6, 2010-06 ,pp. : 1842-1872

MDPI

Access to resources Recommend Favorite